Suppr超能文献

肥胖抑制素可减少啮齿动物的食物摄入量并抑制体重增加。

Obestatin reduces food intake and suppresses body weight gain in rodents.

作者信息

Lagaud Guy J, Young Andy, Acena Auzon, Morton Magda F, Barrett Terrance D, Shankley Nigel P

机构信息

Internal Medicine, Johnson & Johnson Pharmaceutical Research & Development L.L.C., San Diego, CA 92121, USA.

出版信息

Biochem Biophys Res Commun. 2007 May 25;357(1):264-9. doi: 10.1016/j.bbrc.2007.03.138. Epub 2007 Mar 30.

Abstract

Obestatin was recently described as a bioactive peptide encoded for by the same gene as ghrelin but with opposite actions on food intake. Although some groups have confirmed these findings others find no effect. We investigated the effect of obestatin on feeding in rodents over a wide range of doses. Acute administration of obestatin inhibited feeding at doses of 10-100 nmol/kg i.p. in mice and 100-300 nmol/kg i.p. in lean and Zucker fatty rats. Interestingly, the dose-response relationship was U-shaped such that both low and high doses were without effect in either species. Treatment of mice with obestatin over a 7-day period decreased body weight gain and food consumption. Overall, obestatin suppressed food intake and body weight gain in rodent and an unusual dose-response relationship was found. These findings may explain the difficulties in reproducing the effects of obestatin on feeding reported by some groups.

摘要

肥胖抑制素最近被描述为一种生物活性肽,它与胃饥饿素由同一基因编码,但对食物摄入具有相反的作用。尽管一些研究小组证实了这些发现,但其他小组却未发现其有任何作用。我们研究了肥胖抑制素在很宽剂量范围内对啮齿动物进食的影响。腹腔注射时,肥胖抑制素在小鼠中剂量为10 - 100 nmol/kg、在瘦型和 Zucker 肥胖大鼠中剂量为100 - 300 nmol/kg时可抑制进食。有趣的是,剂量 - 反应关系呈U形,即低剂量和高剂量对这两种动物均无作用。对小鼠进行为期7天的肥胖抑制素治疗可降低体重增加和食物消耗。总体而言,肥胖抑制素可抑制啮齿动物的食物摄入和体重增加,并且发现了一种不同寻常的剂量 - 反应关系。这些发现可能解释了一些研究小组在重现肥胖抑制素对进食的影响方面所遇到的困难。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验